Liposomal Drug Delivery System - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2758950
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 141
-
According to latest Research, the global market for Liposomal Drug Delivery System should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Liposomal Drug Delivery System market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Liposomal Drug Delivery System market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Specialty Clinic grew percent.
This report studies and analyses global Liposomal Drug Delivery System status and future trends, to help determine the Liposomal Drug Delivery System market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Liposomal Drug Delivery System, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Liposomal Drug Delivery System market size, history data 2019-2024, and forecast data 2024-2029, (US$ million)
(2) Global Liposomal Drug Delivery System by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Liposomal Drug Delivery System by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Liposomal Drug Delivery System key consuming regions, consumption value and demand structure
(5) Liposomal Drug Delivery System industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson Services, Inc. (U.S.)
Gilead Sciences Inc. (U.S.)
Sun Pharmaceutical Industries Ltd. (India)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd (Israel)
Janssen Pharmaceuticals Inc. (Belgium)
CELSION corporation (U.S.）
Abbott (U.S.)
Ipsen Pharma (France)
Spectrum Pharmaceuticals, Inc. (U.S.)
Takeda Pharmaceutical Company Limited. (Japan)
Market segment by Type, covers
Liposomal Doxorubicin
Liposomal Paclitaxel
Liposomal Amphotericin B
Others
Market segment by Application, can be divided into
Hospital
Specialty Clinic
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Liposomal Drug Delivery System product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Liposomal Drug Delivery System market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Liposomal Drug Delivery System market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Liposomal Drug Delivery System industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Liposomal Drug Delivery System Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Liposomal Drug Delivery System Definition
1.2 Global Liposomal Drug Delivery System Market Size and Forecast
1.3 China Liposomal Drug Delivery System Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Liposomal Drug Delivery System Market Size: China VS Global Growth Rate, 2019-2030
1.6 Liposomal Drug Delivery System Market Dynamics
1.6.1 Liposomal Drug Delivery System Market Drivers
1.6.2 Liposomal Drug Delivery System Market Restraints
1.6.3 Liposomal Drug Delivery System Industry Trends
1.6.4 Liposomal Drug Delivery System Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Liposomal Drug Delivery System, Global Market Share by Company, 2019-2024
2.2 Global Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Liposomal Drug Delivery System Concentration Ratio
2.4 Global Liposomal Drug Delivery System Mergers & Acquisitions, Expansion Plans
2.5 Global Liposomal Drug Delivery System Major Companies Product Type
2.6 Head Office and Liposomal Drug Delivery System Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Liposomal Drug Delivery System, China Market Share by Company, 2019-2024
3.2 China Liposomal Drug Delivery System Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Liposomal Drug Delivery System Industry Chain
4.2 Liposomal Drug Delivery System Upstream Analysis
4.2.1 Liposomal Drug Delivery System Core Raw Materials
4.2.2 Main Manufacturers of Liposomal Drug Delivery System Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Liposomal Drug Delivery System Production Mode
4.6 Liposomal Drug Delivery System Procurement Model
4.7 Liposomal Drug Delivery System Industry Sales Model and Sales Channels
4.7.1 Liposomal Drug Delivery System Sales Model
4.7.2 Liposomal Drug Delivery System Typical Distributors
5 Sights by Type5.1 Liposomal Drug Delivery System Classification
5.1.1 Liposomal Doxorubicin
5.1.2 Liposomal Paclitaxel
5.1.3 Liposomal Amphotericin B
5.1.4 Others5.2 By Type, Global Liposomal Drug Delivery System Consumption Value & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Liposomal Drug Delivery System Consumption Value, 2019-2030
6 Sights by Application6.1 Liposomal Drug Delivery System Segment by Application
6.1.1 Hospital
6.1.2 Specialty Clinic
6.1.3 Others6.2 By Application, Global Liposomal Drug Delivery System Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Liposomal Drug Delivery System Consumption Value, 2019-2030
7 Sales Sights by Region7.1 By Region, Global Liposomal Drug Delivery System Consumption Value, 2019 VS 2024 VS 2030
7.2 By Region, Global Liposomal Drug Delivery System Consumption Value, 2019-2030
7.3 North America
7.3.1 North America Liposomal Drug Delivery System & Forecasts, 2019-2030
7.3.2 By Country, North America Liposomal Drug Delivery System Market Size Market Share7.4 Europe
7.4.1 Europe Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Liposomal Drug Delivery System Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Liposomal Drug Delivery System Market Size Market Share7.6 South America
7.6.1 South America Liposomal Drug Delivery System Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Liposomal Drug Delivery System Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Liposomal Drug Delivery System Market Size & CAGR, 2019 VS 2024 VS 2030
8.2 By Country, Global Liposomal Drug Delivery System Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. Liposomal Drug Delivery System Market Size, 2019-2030
8.3.2 By Type, U.S. Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.3.3 By Application, U.S. Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 20308.4 Europe
8.4.1 Europe Liposomal Drug Delivery System Market Size, 2019-2030
8.4.2 By Type, Europe Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.4.3 By Application, Europe Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 20308.5 China
8.5.1 China Liposomal Drug Delivery System Market Size, 2019-2030
8.5.2 By Type, China Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.5.3 By Application, China Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 20308.6 Japan
8.6.1 Japan Liposomal Drug Delivery System Market Size, 2019-2030
8.6.2 By Type, Japan Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.6.3 By Application, Japan Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Liposomal Drug Delivery System Market Size, 2019-2030
8.7.2 By Type, South Korea Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.7.3 By Application, South Korea Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Liposomal Drug Delivery System Market Size, 2019-2030
8.8.2 By Type, Southeast Asia Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.8.3 By Application, Southeast Asia Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.9 India
8.9.1 India Liposomal Drug Delivery System Market Size, 2019-2030
8.9.2 By Type, India Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.9.3 By Application, India Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 20308.10 Middle East & Africa
8.10.1 Middle East & Africa Liposomal Drug Delivery System Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
8.10.3 By Application, Middle East & Africa Liposomal Drug Delivery System Consumption Value Market Share, 2024 VS 2030
9 Company Profile9.1 Johnson & Johnson Services, Inc. (U.S.)
9.1.1 Johnson & Johnson Services, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.1.2 Johnson & Johnson Services, Inc. (U.S.) Company Profile and Main Business
9.1.3 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.1.4 Johnson & Johnson Services, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.1.5 Johnson & Johnson Services, Inc. (U.S.) Recent Developments9.2 Gilead Sciences Inc. (U.S.)
9.2.1 Gilead Sciences Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.2.2 Gilead Sciences Inc. (U.S.) Company Profile and Main Business
9.2.3 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.2.4 Gilead Sciences Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.2.5 Gilead Sciences Inc. (U.S.) Recent Developments9.3 Sun Pharmaceutical Industries Ltd. (India)
9.3.1 Sun Pharmaceutical Industries Ltd. (India) Company Information, Head Office, Market Area and Industry Position
9.3.2 Sun Pharmaceutical Industries Ltd. (India) Company Profile and Main Business
9.3.3 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Models, Specifications and Application
9.3.4 Sun Pharmaceutical Industries Ltd. (India) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.3.5 Sun Pharmaceutical Industries Ltd. (India) Recent Developments9.4 Novartis AG (Switzerland)
9.4.1 Novartis AG (Switzerland) Company Information, Head Office, Market Area and Industry Position
9.4.2 Novartis AG (Switzerland) Company Profile and Main Business
9.4.3 Novartis AG (Switzerland) Liposomal Drug Delivery System Models, Specifications and Application
9.4.4 Novartis AG (Switzerland) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.4.5 Novartis AG (Switzerland) Recent Developments9.5 Teva Pharmaceutical Industries Ltd (Israel)
9.5.1 Teva Pharmaceutical Industries Ltd (Israel) Company Information, Head Office, Market Area and Industry Position
9.5.2 Teva Pharmaceutical Industries Ltd (Israel) Company Profile and Main Business
9.5.3 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Models, Specifications and Application
9.5.4 Teva Pharmaceutical Industries Ltd (Israel) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.5.5 Teva Pharmaceutical Industries Ltd (Israel) Recent Developments9.6 Janssen Pharmaceuticals Inc. (Belgium)
9.6.1 Janssen Pharmaceuticals Inc. (Belgium) Company Information, Head Office, Market Area and Industry Position
9.6.2 Janssen Pharmaceuticals Inc. (Belgium) Company Profile and Main Business
9.6.3 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Models, Specifications and Application
9.6.4 Janssen Pharmaceuticals Inc. (Belgium) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.6.5 Janssen Pharmaceuticals Inc. (Belgium) Recent Developments
9.7 CELSION corporation (U.S.）
9.7.1 CELSION corporation (U.S.） Company Information, Head Office, Market Area and Industry Position
9.7.2 CELSION corporation (U.S.） Company Profile and Main Business
9.7.3 CELSION corporation (U.S.） Liposomal Drug Delivery System Models, Specifications and Application
9.7.4 CELSION corporation (U.S.） Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.7.5 CELSION corporation (U.S.） Recent Developments
9.8 Abbott (U.S.)
9.8.1 Abbott (U.S.) Company Information, Head Office, Market Area and Industry Position
9.8.2 Abbott (U.S.) Company Profile and Main Business
9.8.3 Abbott (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.8.4 Abbott (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.8.5 Abbott (U.S.) Recent Developments
9.9 Ipsen Pharma (France)
9.9.1 Ipsen Pharma (France) Company Information, Head Office, Market Area and Industry Position
9.9.2 Ipsen Pharma (France) Company Profile and Main Business
9.9.3 Ipsen Pharma (France) Liposomal Drug Delivery System Models, Specifications and Application
9.9.4 Ipsen Pharma (France) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.9.5 Ipsen Pharma (France) Recent Developments9.10 Spectrum Pharmaceuticals, Inc. (U.S.)
9.10.1 Spectrum Pharmaceuticals, Inc. (U.S.) Company Information, Head Office, Market Area and Industry Position
9.10.2 Spectrum Pharmaceuticals, Inc. (U.S.) Company Profile and Main Business
9.10.3 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Models, Specifications and Application
9.10.4 Spectrum Pharmaceuticals, Inc. (U.S.) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.10.5 Spectrum Pharmaceuticals, Inc. (U.S.) Recent Developments
9.11 Takeda Pharmaceutical Company Limited. (Japan)
9.11.1 Takeda Pharmaceutical Company Limited. (Japan) Company Information, Head Office, Market Area and Industry Position
9.11.2 Takeda Pharmaceutical Company Limited. (Japan) Company Profile and Main Business
9.11.3 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Models, Specifications and Application
9.11.4 Takeda Pharmaceutical Company Limited. (Japan) Liposomal Drug Delivery System Revenue and Gross Margin, 2019-2024
9.11.5 Takeda Pharmaceutical Company Limited. (Japan) Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Liposomal Drug Delivery System Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Liposomal Drug Delivery System Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Liposomal Drug Delivery System Global and China Top Players Market has been segmented into
The Liposomal Drug Delivery System Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
According to the Liposomal Drug Delivery System Global and China Top Players Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
This latest research publication on the Liposomal Drug Delivery System Global and China Top Players Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.
